Current molecular changes in colorectal tumors are usually linked to the traditional determination of somatic mutations in well-known tumor-suppressor genes or oncogenes, such as p53, KRAS, and BRAF [21]. The gene discussed is TP53; the disease is colorectal neoplasm.